The nephrology and urology devices market size has grown strongly in recent years. It will grow from $58.39 billion in 2025 to $61.74 billion in 2026 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to rising prevalence of chronic kidney disease, expansion of dialysis treatment infrastructure, increasing incidence of urological disorders, growing demand for minimally invasive procedures, availability of advanced endoscopy devices.
The nephrology and urology devices market size is expected to see strong growth in the next few years. It will grow to $78.78 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing adoption of home-based dialysis solutions, rising demand for precision urology treatments, expansion of aging population healthcare needs, growing investments in renal care innovation, increasing focus on value-based urology care. Major trends in the forecast period include increasing adoption of advanced dialysis technologies, rising use of minimally invasive urology devices, growing integration of laser-based treatment systems, expansion of disposable and single-use devices, enhanced focus on patient-centric treatment solutions.
The increasing prevalence of kidney and urinary tract diseases is set to drive the growth of the nephrology and urology devices market in the future. These health issues affect various components of the urinary system, including the kidneys, ureters, bladder, and urethra. Medical devices in the field of nephrology and urology play a crucial role in addressing conditions like chronic kidney disease (CKD) and end-stage renal disease (ESRD). For example, in June 2023, Kidney Research UK reported that over 7.19 million people in the UK were affected by chronic kidney disease, which accounts for more than 10% of the UK's population. The number is projected to increase to 7.61 million people by 2033. Consequently, the rising incidence of kidney and urinary tract diseases is expected to be a significant driver of growth in the nephrology and urology devices market.
Leading companies in the nephrology and urology devices market are leveraging advanced technologies, such as artificial intelligence (AI), to improve diagnostic accuracy and expand treatment options for patients. AI tools, which encompass software applications and systems utilizing machine learning algorithms, data analytics, and other advanced computational techniques, are designed to enhance healthcare outcomes. For example, in April 2024, Dornier MedTech GmbH, a Germany-based medical device company, launched UroGPT. This AI-powered tool, designed specifically for kidney stone patients, uses natural language processing to provide real-time, personalized support. Acting as a chatbot, UroGPT interprets patient queries about kidney stones and delivers tailored, easy-to-understand responses, addressing patients' concerns and anxieties effectively.
In November 2024, Boston Scientific Corporation, a U.S.-based global medical device company, completed the acquisition of Axonics, Inc. for approximately $3.7 billion. Through this acquisition, Boston Scientific aims to expand its presence in the sacral neuromodulation (SNM) market, a high-growth segment within urology by integrating Axonics’s R20 and F15 neuromodulation systems used to treat urinary and bowel dysfunction. Axonics, Inc. is a U.S.-based medical technology company specializing in implantable neuromodulation solutions for urology and pelvic health disorders.
Major companies operating in the nephrology and urology devices market are Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Cook Group Incorporated, B. Braun Group, C. R. Bard Inc., Boston Scientific Corporation, Coloplast Private Limited, Convatec Group plc, Hollister Incorporated, Teleflex Incorporated, J and M Urinary Catheters LLC, NxStage Medical Inc., Olympus Corporation, Stryker Corporation, Karl Storz Se & Co. KG, Richard Wolf GmbH, Becton Dickinson and Company, Terumo Corporation, Uromed Kurt Drews KG, Urocare Products Inc., Urotech GmbH, Wellspect Healthcare AB, Medtronic plc, Dornier MedTech GmbH, Nikkiso Co. Ltd., Siemens Healthineers AG, Nipro Corporation, Urologix LLC, Johnson & Johnson, Abbott Laboratories.
North America was the largest region in the global nephrology and urology devices market in 2025. Asia-Pacific was the second largest region in the global nephrology and urology devices market. The regions covered in the nephrology and urology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nephrology and urology devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the nephrology and urology devices market by increasing costs of imported dialysis components, laser systems, endoscopic instruments, electronic monitoring units, and specialized disposables. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported high-precision medical devices, while Asia-Pacific faces higher manufacturing and export costs. These tariffs are increasing treatment equipment costs and affecting capital planning. However, they are also encouraging domestic device production, regional supplier partnerships, and localized innovation in renal and urology care technologies.
The nephrology and urology devices market research report is one of a series of new reports that provides nephrology and urology devices market statistics, including nephrology and urology devices industry global market size, regional shares, competitors with a nephrology and urology devices market share, detailed nephrology and urology devices market segments, market trends and opportunities, and any further data you may need to thrive in the nephrology and urology devices industry. This nephrology and urology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Nephrology and urology devices play a crucial role in the diagnosis and treatment of kidney and genitourinary diseases.
The primary categories of nephrology and urology devices encompass dialysis devices and equipment, urinary stone treatment devices and equipment, urinary incontinence and pelvic organ prolapse devices and equipment, benign prostatic hyperplasia (BPH) treatment devices and equipment, as well as endoscopy devices and equipment. Dialysis devices and equipment are instrumental in the dialysis process, functioning as artificial kidneys to filter a patient's blood, eliminating excess water and waste products when kidney function is impaired. Expenditure for these devices can be both public and private. These devices and equipment utilize instruments/equipment and disposables, serving a wide range of end-users including hospitals and clinics, diagnostic laboratories, and others.
The nephrology and urology devices market consist of sales of instruments such as ureteral catheters, PCN catheters, urinary stents, stone baskets, urology guidewires, and renal dilators that are used to treat kidney and genitourinary diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The nephrology and urology devices market size is expected to see strong growth in the next few years. It will grow to $78.78 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing adoption of home-based dialysis solutions, rising demand for precision urology treatments, expansion of aging population healthcare needs, growing investments in renal care innovation, increasing focus on value-based urology care. Major trends in the forecast period include increasing adoption of advanced dialysis technologies, rising use of minimally invasive urology devices, growing integration of laser-based treatment systems, expansion of disposable and single-use devices, enhanced focus on patient-centric treatment solutions.
The increasing prevalence of kidney and urinary tract diseases is set to drive the growth of the nephrology and urology devices market in the future. These health issues affect various components of the urinary system, including the kidneys, ureters, bladder, and urethra. Medical devices in the field of nephrology and urology play a crucial role in addressing conditions like chronic kidney disease (CKD) and end-stage renal disease (ESRD). For example, in June 2023, Kidney Research UK reported that over 7.19 million people in the UK were affected by chronic kidney disease, which accounts for more than 10% of the UK's population. The number is projected to increase to 7.61 million people by 2033. Consequently, the rising incidence of kidney and urinary tract diseases is expected to be a significant driver of growth in the nephrology and urology devices market.
Leading companies in the nephrology and urology devices market are leveraging advanced technologies, such as artificial intelligence (AI), to improve diagnostic accuracy and expand treatment options for patients. AI tools, which encompass software applications and systems utilizing machine learning algorithms, data analytics, and other advanced computational techniques, are designed to enhance healthcare outcomes. For example, in April 2024, Dornier MedTech GmbH, a Germany-based medical device company, launched UroGPT. This AI-powered tool, designed specifically for kidney stone patients, uses natural language processing to provide real-time, personalized support. Acting as a chatbot, UroGPT interprets patient queries about kidney stones and delivers tailored, easy-to-understand responses, addressing patients' concerns and anxieties effectively.
In November 2024, Boston Scientific Corporation, a U.S.-based global medical device company, completed the acquisition of Axonics, Inc. for approximately $3.7 billion. Through this acquisition, Boston Scientific aims to expand its presence in the sacral neuromodulation (SNM) market, a high-growth segment within urology by integrating Axonics’s R20 and F15 neuromodulation systems used to treat urinary and bowel dysfunction. Axonics, Inc. is a U.S.-based medical technology company specializing in implantable neuromodulation solutions for urology and pelvic health disorders.
Major companies operating in the nephrology and urology devices market are Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Cook Group Incorporated, B. Braun Group, C. R. Bard Inc., Boston Scientific Corporation, Coloplast Private Limited, Convatec Group plc, Hollister Incorporated, Teleflex Incorporated, J and M Urinary Catheters LLC, NxStage Medical Inc., Olympus Corporation, Stryker Corporation, Karl Storz Se & Co. KG, Richard Wolf GmbH, Becton Dickinson and Company, Terumo Corporation, Uromed Kurt Drews KG, Urocare Products Inc., Urotech GmbH, Wellspect Healthcare AB, Medtronic plc, Dornier MedTech GmbH, Nikkiso Co. Ltd., Siemens Healthineers AG, Nipro Corporation, Urologix LLC, Johnson & Johnson, Abbott Laboratories.
North America was the largest region in the global nephrology and urology devices market in 2025. Asia-Pacific was the second largest region in the global nephrology and urology devices market. The regions covered in the nephrology and urology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nephrology and urology devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the nephrology and urology devices market by increasing costs of imported dialysis components, laser systems, endoscopic instruments, electronic monitoring units, and specialized disposables. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported high-precision medical devices, while Asia-Pacific faces higher manufacturing and export costs. These tariffs are increasing treatment equipment costs and affecting capital planning. However, they are also encouraging domestic device production, regional supplier partnerships, and localized innovation in renal and urology care technologies.
The nephrology and urology devices market research report is one of a series of new reports that provides nephrology and urology devices market statistics, including nephrology and urology devices industry global market size, regional shares, competitors with a nephrology and urology devices market share, detailed nephrology and urology devices market segments, market trends and opportunities, and any further data you may need to thrive in the nephrology and urology devices industry. This nephrology and urology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Nephrology and urology devices play a crucial role in the diagnosis and treatment of kidney and genitourinary diseases.
The primary categories of nephrology and urology devices encompass dialysis devices and equipment, urinary stone treatment devices and equipment, urinary incontinence and pelvic organ prolapse devices and equipment, benign prostatic hyperplasia (BPH) treatment devices and equipment, as well as endoscopy devices and equipment. Dialysis devices and equipment are instrumental in the dialysis process, functioning as artificial kidneys to filter a patient's blood, eliminating excess water and waste products when kidney function is impaired. Expenditure for these devices can be both public and private. These devices and equipment utilize instruments/equipment and disposables, serving a wide range of end-users including hospitals and clinics, diagnostic laboratories, and others.
The nephrology and urology devices market consist of sales of instruments such as ureteral catheters, PCN catheters, urinary stents, stone baskets, urology guidewires, and renal dilators that are used to treat kidney and genitourinary diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Nephrology and Urology Devices Market Characteristics
3. Nephrology and Urology Devices Market Supply Chain Analysis
4. Global Nephrology and Urology Devices Market Trends and Strategies
5. Nephrology and Urology Devices Market Analysis of End Use Industries
7. Global Nephrology and Urology Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Nephrology and Urology Devices Total Addressable Market (TAM) Analysis for the Market
9. Nephrology and Urology Devices Market Segmentation
10. Nephrology and Urology Devices Market Regional and Country Analysis
11. Asia-Pacific Nephrology and Urology Devices Market
12. China Nephrology and Urology Devices Market
13. India Nephrology and Urology Devices Market
14. Japan Nephrology and Urology Devices Market
15. Australia Nephrology and Urology Devices Market
16. Indonesia Nephrology and Urology Devices Market
17. South Korea Nephrology and Urology Devices Market
18. Bangladesh Nephrology and Urology Devices Market
19. Thailand Nephrology and Urology Devices Market
20. Vietnam Nephrology and Urology Devices Market
21. Malaysia Nephrology and Urology Devices Market
22. Singapore Nephrology and Urology Devices Market
23. Philippines Nephrology and Urology Devices Market
24. Hong Kong Nephrology and Urology Devices Market
25. New Zealand Nephrology and Urology Devices Market
26. Taiwan Nephrology and Urology Devices Market
27. South East Asia Nephrology and Urology Devices Market
28. Western Europe Nephrology and Urology Devices Market
29. UK Nephrology and Urology Devices Market
30. Germany Nephrology and Urology Devices Market
31. France Nephrology and Urology Devices Market
32. Italy Nephrology and Urology Devices Market
33. Spain Nephrology and Urology Devices Market
34. Austria Nephrology and Urology Devices Market
35. Belgium Nephrology and Urology Devices Market
36. Denmark Nephrology and Urology Devices Market
37. Finland Nephrology and Urology Devices Market
38. Ireland Nephrology and Urology Devices Market
39. Netherlands Nephrology and Urology Devices Market
40. Norway Nephrology and Urology Devices Market
41. Portugal Nephrology and Urology Devices Market
42. Sweden Nephrology and Urology Devices Market
42. Switzerland Nephrology and Urology Devices Market
43. Eastern Europe Nephrology and Urology Devices Market
44. Russia Nephrology and Urology Devices Market
45. Czech Republic Nephrology and Urology Devices Market
46. Poland Nephrology and Urology Devices Market
47. Romania Nephrology and Urology Devices Market
48. Ukraine Nephrology and Urology Devices Market
49. North America Nephrology and Urology Devices Market
50. USA Nephrology and Urology Devices Market
51. Canada Nephrology and Urology Devices Market
52. Mexico Nephrology and Urology Devices Market
53. South America Nephrology and Urology Devices Market
54. Brazil Nephrology and Urology Devices Market
55. Chile Nephrology and Urology Devices Market
56. Argentina Nephrology and Urology Devices Market
57. Colombia Nephrology and Urology Devices Market
58. Peru Nephrology and Urology Devices Market
59. Middle East Nephrology and Urology Devices Market
60. Saudi Arabia Nephrology and Urology Devices Market
61. Israel Nephrology and Urology Devices Market
62. Iran Nephrology and Urology Devices Market
63. Turkey Nephrology and Urology Devices Market
64. United Arab Emirates Nephrology and Urology Devices Market
65. Africa Nephrology and Urology Devices Market
66. Egypt Nephrology and Urology Devices Market
67. Nigeria Nephrology and Urology Devices Market
68. South Africa Nephrology and Urology Devices Market
70. Nephrology and Urology Devices Market Competitive Landscape and Company Profiles
71. Nephrology and Urology Devices Market Other Major and Innovative Companies
74. Nephrology and Urology Devices Market High Potential Countries, Segments and Strategies
75. Appendix
List of Tables
Executive Summary
Nephrology And Urology Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses nephrology and urology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for nephrology and urology devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nephrology and urology devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device: Dialysis Devices And Equipment; Urinary Stone Treatment Devices And Equipment; Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment; Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment; Endoscopy Devices And Equipment2) By Type of Expenditure: Public; Private
3) By End User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Dialysis Devices And Equipment: Hemodialysis Machines; Peritoneal Dialysis Machines; Dialyzers (Hemodialysis Filters); Dialysis Concentrates; Dialysis Catheters2) By Urinary Stone Treatment Devices And Equipment: Lithotripters (Shock Wave Lithotripsy Machines); Laser Lithotripters; Ureteroscopes; Nephroscopes; Stone Removal Catheters
3) By Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment: Urinary Incontinence Devices (Urinary Catheters, External Urinary Collection Devices); Pelvic Floor Electrical Stimulation Devices; Vaginal Inserts; Slings For Pelvic Organ Prolapse
4) By Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment: Prostate Stents; Laser BPH Devices; Transurethral Resection Of The Prostate (TURP) Devices; Urolift Systems; GreenLight Laser Systems
5) By Endoscopy Devices And Equipment: Cystoscopes; Ureteroscopes; Renal Biopsy Instruments; Laparoscopes; Rigid And Flexible Endoscopes
Companies Mentioned: Baxter International Inc.; Fresenius Medical Care AG & Co. KGaA; Cook Group Incorporated; B. Braun Group; C. R. Bard Inc.; Boston Scientific Corporation; Coloplast Private Limited; Convatec Group plc; Hollister Incorporated; Teleflex Incorporated; J and M Urinary Catheters LLC; NxStage Medical Inc.; Olympus Corporation; Stryker Corporation; Karl Storz Se & Co. KG; Richard Wolf GmbH; Becton Dickinson and Company; Terumo Corporation; Uromed Kurt Drews KG; Urocare Products Inc.; Urotech GmbH; Wellspect Healthcare AB; Medtronic plc; Dornier MedTech GmbH; Nikkiso Co. Ltd.; Siemens Healthineers AG; Nipro Corporation; Urologix LLC; Johnson & Johnson; Abbott Laboratories
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Nephrology and Urology Devices market report include:- Baxter International Inc.
- Fresenius Medical Care AG & Co. KGaA
- Cook Group Incorporated
- B. Braun Group
- C. R. Bard Inc.
- Boston Scientific Corporation
- Coloplast Private Limited
- Convatec Group plc
- Hollister Incorporated
- Teleflex Incorporated
- J and M Urinary Catheters LLC
- NxStage Medical Inc.
- Olympus Corporation
- Stryker Corporation
- Karl Storz Se & Co. KG
- Richard Wolf GmbH
- Becton Dickinson and Company
- Terumo Corporation
- Uromed Kurt Drews KG
- Urocare Products Inc.
- Urotech GmbH
- Wellspect Healthcare AB
- Medtronic plc
- Dornier MedTech GmbH
- Nikkiso Co. Ltd.
- Siemens Healthineers AG
- Nipro Corporation
- Urologix LLC
- Johnson & Johnson
- Abbott Laboratories
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 61.74 Billion |
| Forecasted Market Value ( USD | $ 78.78 Billion |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
